Open Access Journal of Biomedical Science最新文献

筛选
英文 中文
Satisfaction Assessment of Telephone Consultations among 270 Primary Health Care Physicians During the COVID-19 Pandemic in Qatar 新冠肺炎大流行期间卡塔尔270名初级卫生保健医生电话咨询满意度评估
Open Access Journal of Biomedical Science Pub Date : 2021-12-23 DOI: 10.38125/oajbs.000364
Ahsan Ali Siddiqui
{"title":"Satisfaction Assessment of Telephone Consultations among 270 Primary Health Care Physicians During the COVID-19 Pandemic in Qatar","authors":"Ahsan Ali Siddiqui","doi":"10.38125/oajbs.000364","DOIUrl":"https://doi.org/10.38125/oajbs.000364","url":null,"abstract":"","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133761058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Satisfaction Assessment of Telephone Consultations among 270 Primary Health Care Physicians During the COVID-19 Pandemic in Qatar" “卡塔尔新冠肺炎大流行期间270名初级卫生保健医生电话咨询满意度评估”
Open Access Journal of Biomedical Science Pub Date : 2021-12-23 DOI: 10.38125/oajbs.000363
Moqthiar Sharief
{"title":"\"Satisfaction Assessment of Telephone Consultations among 270 Primary Health Care Physicians During the COVID-19 Pandemic in Qatar\"","authors":"Moqthiar Sharief","doi":"10.38125/oajbs.000363","DOIUrl":"https://doi.org/10.38125/oajbs.000363","url":null,"abstract":"With over 270 million people worldwide infected with COVID-19 and over 5,3 million deaths since the pandemic began [1] the World Health Organization (WHO) has recommended the implementation of public health measures such as the quarantine of all individuals suspected of infection for 14 days [2-5]. Numerous countries have also implemented “social distancing” and “lock-downs” of varying degrees of severity for entire communities in an effort to contain the spread of COVID-19 [6-15]. ABSTRACT","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"140 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122920642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Dub3-Snail1 in Metastasis of Breast Cancer Dub3-Snail1在乳腺癌转移中的作用
Open Access Journal of Biomedical Science Pub Date : 2021-12-22 DOI: 10.38125/oajbs.000362
Wenlin Chen
{"title":"The Role of Dub3-Snail1 in Metastasis of Breast Cancer","authors":"Wenlin Chen","doi":"10.38125/oajbs.000362","DOIUrl":"https://doi.org/10.38125/oajbs.000362","url":null,"abstract":"alters protein activity, interaction, ABSTRACT Nowadays, oncogenic proteins have been widely discovered and identified, scarcely ever oncogenic proteins can be well applied as drug targets, which is a difficult problem for translational medicine of breast cancer. Dub3, overexpressed in breast cancer, is a Snail1 deubiquitination enzyme that can interact with Snail1 and stabilize it. Snail1 is a key transcription factor in epithelial-mesenchymal transformation (EMT) and breast cancer metastasis and is prone to ubiquitination and degradation. Dysregulation of Dub3 can lead to Snail1 instability and inhibit the process of EMT, thereby reducing the migration, invasion and metastasis of tumor cells. Dub3 will provide potential of targeted therapies for breast cancer patients. This review expounds expression and mechanism of Dub3 and Snail1 in breast cancer and reviews the playing role of Dub3-Snail1 signaling axis in breast cancer.","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"116 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124302410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Advances in Biosensor Technology 生物传感器技术的最新进展
Open Access Journal of Biomedical Science Pub Date : 2021-12-13 DOI: 10.38125/oajbs.000361
A. Ahmadi
{"title":"Recent Advances in Biosensor Technology","authors":"A. Ahmadi","doi":"10.38125/oajbs.000361","DOIUrl":"https://doi.org/10.38125/oajbs.000361","url":null,"abstract":"Biosensors or biosensors are one of the most valuable and emerging technologies in recent years [1]. These sensors are installed on smart devices such as mobile phones, smart watches, smart bracelets, smart car steering wheels and more. The market for biosensors can be categorized by type (patch sensor and builtin device), product (wearable and non-wearable), technology (electrochemical and optical), application (POC, home diagnostics, research laboratory, food, and beverage) and geography. Global Forecast By 2024, the overall biosensor market is projected to grow from $21.2 billion in 2019 to $31.5 billion in 2024 with a combined annual growth rate of 8.3% over the forecast period. This growth is likely to be exacerbated by sustained technological advances in biosensor ecosystems, increased use of biosensors for non-medical applications, profitable growth in POC (clinical instant) diagnostics, and increased demand for glucose monitoring systems [2].","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125520735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Development of High Throughput Screening to Discover SARS-CoV-2 Main Protease Inhibitors with NanoBit Complementation 基于纳米位互补的SARS-CoV-2主要蛋白酶抑制剂高通量筛选研究进展
Open Access Journal of Biomedical Science Pub Date : 2021-12-10 DOI: 10.38125/oajbs.000360
Jianxin Liu
{"title":"Development of High Throughput Screening to Discover SARS-CoV-2 Main Protease Inhibitors with NanoBit Complementation","authors":"Jianxin Liu","doi":"10.38125/oajbs.000360","DOIUrl":"https://doi.org/10.38125/oajbs.000360","url":null,"abstract":"of High Throughput Screening to Discover SARS-CoV-2 Main Protease Inhibitors with NanoBit ABSTRACT SARS-CoV-2 has become a serious global public health problem and there is lack of effective drugs to fight it. Main protease (M pro ) of SARS-CoV-2 is an important antiviral drug target. We aim to establish a high-throughput screening (HTS) assay to identify inhibitors of SARS- CoV-2 M pro . A M pro NanoBiT assay for HTS was developed by using NanoBiT complementary strategy. M pro peptide substrate was flanked by subunits of Nano luciferase (NanoLuc), SmBiT and LgBiT respectively at the amino and carboxyl termini to obtain the structure M pro cleavage site-NanoBiT. M pro cleavage site-NanoBiT showed strong NanoLuc activity, which was modulated with M pro peptide digestion, indicating the inhibitory effect of compounds on M pro could be read out with NanoLuc activity. We optimized the experiment conditions including the quantity of M pro and M pro cleavage site-NanoBiT, DMSO tolerance, enzyme digestion time, and plate readout time after adding NanoLuc substrate. We further evaluated with two M pro reference inhibitors, GC376 and M pro inhibitor 11a, and found the assay was suitable for HTS of M pro inhibitors. The miniaturized 384-well plate format assay was further used to screen 6,400 compounds from FDA-approved Drug Library and Natural Bioactive Compound Library. Control experiments showed a significant separation of relative activity of the negative and positive controls leading to an acceptable HTS Z’ value of 0.67, indicating satisfactory assay performance. Our results demonstrated that our established M pro NanoBiT assay by inserting protease substrate peptides between SmBiT and LgBiT of NanoBiT could be applied for discovery of inhibitors of different proteases.","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123237254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes, Therapy Options and Risk Factor Impact Analysis on 1077 Patients Hospitalized for Covid-19 1077例新冠肺炎住院患者临床结局、治疗方案及危险因素影响分析
Open Access Journal of Biomedical Science Pub Date : 2021-12-09 DOI: 10.38125/oajbs.000359
Š. Cimrman
{"title":"Clinical Outcomes, Therapy Options and Risk Factor Impact Analysis on 1077 Patients Hospitalized for Covid-19","authors":"Š. Cimrman","doi":"10.38125/oajbs.000359","DOIUrl":"https://doi.org/10.38125/oajbs.000359","url":null,"abstract":"our cohort. ABSTRACT Purpose : In this retrospective study, a cohort of 1077 patients with covid-19 hospitalized in Masaryk hospital in Ústí nad Labem, Czech Republic, is examined. Several suggested risk factors for covid-19 are described and the impact of their presence on clinical outcome is explored. Treatment options for covid-19 are discussed. Methods : Using statistical analysis (Fisher’s exact test, logistic regression, induction of decision trees and random forests), the authors identify clinical and laboratory risk factors for mortality rate, development of severe disease and longer duration of hospitalization. Results : Age was confirmed to be the most impactful risk factor on mortality and length of hospitalization (95% CI 4.62-11.67, p =<0.00001). Obesity did not increase mortality but led to increased disease severity (95% CI 1.28-2.40, p =<0.00329). Diabetes (95% CI 1.68-3.17, p =<0.00001), heart disease (95% CI 2.85 -5.47, p =<0.00001), chronic kidney disease (95% CI 3.27-7.04, p =0.00001) and cancer (95% CI 1.36-3.55, p =0.00544) had an impact on mortality. Lung disease and immune system suppression were not established as significant risk factors. CRP (95% CI 2.7-5.61, p =<0.00001), D-dimer (95% CI 1.60-3.25, p =0.00002), procalcitonin (95% CI 4.24-11.95, p =<0.00001) and lymphocyte count (95% CI 2.11-4.03, p =<0.00001) are found to be significant early laboratory risk indicators in patients with covid-19. Conclusion : We suggest the presence of confirmed risk factors and laboratory markers to be evaluated and considered in determining initial treatment options provided to patients with covid-19.","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"242 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121167358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Multiple Sclerosis (MS) on Central Nervous System (CNS) 多发性硬化(MS)对中枢神经系统(CNS)的影响
Open Access Journal of Biomedical Science Pub Date : 2021-12-08 DOI: 10.38125/oajbs.000358
A. Ahmadi
{"title":"The Effect of Multiple Sclerosis (MS) on Central Nervous System (CNS)","authors":"A. Ahmadi","doi":"10.38125/oajbs.000358","DOIUrl":"https://doi.org/10.38125/oajbs.000358","url":null,"abstract":"Multiple sclerosis (MS) is an autoimmune disorder of the CNS in which myelin components are specifically targeted by the immune system and lead to the destruction of myelin axons and associated debilitating symptoms [1-3]. Also, according to studies, no effective treatment for this disease has been found. Therefore, a safe and effective treatment option for MS is needed. Also, the central nervous system (CNS) is separated from the immune system by a blood-brain barrier and is traditionally considered “immune system protection”, and immune cells are also able to target the brain and lead to CNS autoimmune disorders Pahan et al. [4]. An article measuring the effects of cinnamon on MS mice used cinnamon and the brown bark of the cinnamon tree, which has been used as a spice or flavoring around the world for centuries. In addition, medieval physicians used cinnamon for medical purposes to treat a variety of disorders such as osteoarthritis, cough, hoarseness, sore throat, etc. Also, according to the findings of various articles, the results show that widespread inflammation, Loss of regulatory T cells (Tregs), autoimmune Th1 and Th17 cell hyperactivity, failure of the cerebral blood-brain barrier (BBB) and blood-spinal cord barrier (BSB), and loss of light-protective molecules in the CNS are some of the symptoms that Demystifying manifestations are required in MS [1-3]. Interestingly, NaB treatment is able to inhibit the expression of proinflammatory molecules in cultured astrocytes and microglia [4]. Reversal of NaB by inhibiting NF-κB activation and expression of nitric oxide synthase (iNOS) by mevalonate, 3-hydroxy-3methylglutaryl-coenzyme A and farnesyl pyrophosphate, mediators of the mevalonate pathway, in active astrocytes suggests that NaB. It has an inflammatory effect by inhibiting the cholesterolbiosynthesis pathway However, although NaB is able to lower cholesterol levels, cholesterol has no role in inhibiting NaBmediated iNOS [4]. Also, in an article by Brahmachari et al. [4], they measured the effects of cinnamon on mice with MS in which NaB reduced NF-κB activation and iNOS expression in glial cells by reducing p21ras activation, according to which oral administration of cinnamon powder [5] and drinking water containing NaB metabolite [4] suppresses iNOS and IL-1β expression in vivo in the spinal cord and cerebellum of EAE mice, these findings suggest that cinnamon is able to reduce in vivo inflammation in rat CNS EAE is also another feature of neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), cinnamon and NaB. It also improves hippocampal function in an animal model of AD [6] and from nigrostriatum. Animal model PD Protects [7].","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"101 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124628395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Do We Know About the Impacts of Novel Coronavirus (SARS-Cov-2) on Freshwater Ecosystems? 关于新型冠状病毒(SARS-Cov-2)对淡水生态系统的影响,我们知道什么?
Open Access Journal of Biomedical Science Pub Date : 2021-12-07 DOI: 10.38125/oajbs.000357
Didem Gökçe
{"title":"What Do We Know About the Impacts of Novel Coronavirus (SARS-Cov-2) on Freshwater Ecosystems?","authors":"Didem Gökçe","doi":"10.38125/oajbs.000357","DOIUrl":"https://doi.org/10.38125/oajbs.000357","url":null,"abstract":"Epidemiological alterations in COVID-19 infection monitored for a long term the potential pathways of contagion, as well as the adaptation, evolution, and virus spread among humans and possible intermediate zoonotic hosts and reservoirs. In the present review, widespread transmission routes and pressures on water resources and freshwater ecosystems under the threat of COVID-19 with high mutation rate were evaluated. The climatic structure, aquatic ecosystem, water consumption, and wastewater ABSTRACT The coronavirus pandemic (COVID-19), which has numerous effects in the world, has crucial importance for water resources. The COVID-19 pandemic has had an unpredictable impact on worldwide societies and the economies. On the other hand, lockdown and isolation implemented due to pandemic have decreased environmental damage such as air pollution and gas emissions. However, its unexpected effect was the increase of plastic pollution, medical waste, and wastewater as well as the presence of SARS-CoV-2 in aquatic ecosystem. The present study discussed the potential of the COVID-19 on freshwater ecosystems contaminated by wastewater discharge. The effects of climate change and the use of contaminated waters on spread of COVID-19 were addressed and the related situation in Turkey was discussed.","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115312156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Related to Oral Care and Oral Health Education of Implant Patients 与种植患者口腔护理及口腔健康教育有关
Open Access Journal of Biomedical Science Pub Date : 2021-12-03 DOI: 10.38125/oajbs.000356
Hee Jn
{"title":"Related to Oral Care and Oral Health Education of Implant Patients","authors":"Hee Jn","doi":"10.38125/oajbs.000356","DOIUrl":"https://doi.org/10.38125/oajbs.000356","url":null,"abstract":"","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"74 6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130895382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine Exemptions and Vaccination Coverage in the United States 美国的疫苗豁免和疫苗接种覆盖率
Open Access Journal of Biomedical Science Pub Date : 2021-12-02 DOI: 10.38125/oajbs.000355
A. Choudhury
{"title":"Vaccine Exemptions and Vaccination Coverage in the United States","authors":"A. Choudhury","doi":"10.38125/oajbs.000355","DOIUrl":"https://doi.org/10.38125/oajbs.000355","url":null,"abstract":"The creation of vaccines at the end of the 1700s has been one of the leading scientific advancements to improve public health. Diseases like smallpox and polio that once plagued humanity with devastating long-term health effects have been eradicated in most countries through the adoption of vaccines. However, despite developments in vaccines, the US has seen a decline in vaccination coverage in recent decades. This could be due to the presence of exemptions to vaccines that help prevent said outbreaks. In the United States there are three available exemptions to vaccination: medical, religious, and personal/philosophical.","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126954602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信